{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T20:36:32Z","timestamp":1776544592989,"version":"3.51.2"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/ijg.0b013e3181ccb794","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T08:13:12Z","timestamp":1269418392000},"page":"622-626","source":"Crossref","is-referenced-by-count":30,"title":["Management of Neovascular Glaucoma With Panretinal Photocoagulation, Intravitreal Bevacizumab, and Subsequent Trabeculectomy With Mitomycin C"],"prefix":"10.1097","volume":"19","author":[{"given":"Ayman A.","family":"Alkawas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezzat A.","family":"Shahien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atef M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210208","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0039-6257(81)90063-1","article-title":"Neovascular glaucoma: current management.","volume":"26","author":"Weber","year":"1981","journal-title":"Surv Ophthalmol"},{"key":"R2-11-20210208","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0161-6420(82)34672-2","article-title":"Filtration surgery in the treatment of neovascular glaucoma.","volume":"89","author":"Allen","year":"1982","journal-title":"Ophthalmology"},{"key":"R3-11-20210208","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1755-3768.1988.tb04049.x","article-title":"Treatment of diabetic neovascular glaucoma by panretinal ablation and trabeculectomy.","volume":"66","author":"Fernandez-Vigo","year":"1988","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R4-11-20210208","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1001\/archopht.1979.01020020555011","article-title":"A modified filtering operation for neovascular glaucoma.","volume":"97","author":"Herschler","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"R5-11-20210208","first-page":"181","article-title":"Modified trabeculectomy: a new procedure for neovascular glaucoma.","volume":"11","author":"Lee","year":"1980","journal-title":"Ophthalmic Surg"},{"key":"R6-11-20210208","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/archopht.1983.01040010745008","article-title":"Eyes with end-stage neovascular glaucoma: natural history following successful modified filtering operation.","volume":"101","author":"Parrish","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"R7-11-20210208","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0161-6420(92)31951-7","article-title":"Intraoperative mitomycin versus postoperative 5-fluorouracil in high risk glaucoma filtering surgery.","volume":"99","author":"Skuta","year":"1992","journal-title":"Ophthalmology"},{"key":"R8-11-20210208","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0161-6420(98)92782-8","article-title":"Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma.","volume":"105","author":"Tripathi","year":"2001","journal-title":"Ophthalmology"},{"key":"R9-11-20210208","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archopht.1996.01100140172010","article-title":"Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a non-human primate.","volume":"114","author":"Tolentino","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R10-11-20210208","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"R11-11-20210208","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1442-9071.2007.01521.x","article-title":"Bevacizumab (Avastin) for the treatment of neovascular glaucoma.","volume":"35","author":"Chilov","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"R12-11-20210208","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2006.02.045","article-title":"Intracameral bevacizumab for iris rubeosis.","volume":"142","author":"Grisanti","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R14-11-20210208","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1600-0420.2006.00731.x","article-title":"Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.","volume":"84","author":"Silva Paula","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"R15-11-20210208","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2006.06.066","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.","volume":"142","author":"Iliev","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R16-11-20210208","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/IJG.0b013e318170a747","article-title":"Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.","volume":"18","author":"Duch","year":"2009","journal-title":"J Glaucoma"},{"key":"R17-11-20210208","first-page":"287","article-title":"Mitomycin-C-augmented trabeculectomy for neovascular glaucoma. A preliminary report.","volume":"50","author":"Mandal","year":"2008","journal-title":"Indian J Ophthalmol"},{"key":"R18-11-20210208","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/bjo.83.7.814","article-title":"Risk factors for failures of trabeculectomies performed without antimetabolites.","volume":"83","author":"Mietz","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R19-11-20210208","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0420.2006.00810.x","article-title":"The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up.","volume":"85","author":"Sisto","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"R20-11-20210208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0039-6257(96)80023-3","article-title":"Ciliary body ablation: where are we and how did we get here.","volume":"41","author":"Mastrobattista","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"R21-11-20210208","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/eye.2008.113","article-title":"Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients.","volume":"23","author":"Cornish","year":"2009","journal-title":"Eye"},{"key":"R22-11-20210208","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/IAE.0b013e3181679c0b","article-title":"Combination intravitreal bevacizumabpanretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.","volume":"28","author":"Ehlers","year":"2008","journal-title":"Retina"},{"key":"R23-11-20210208","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin).","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"R24-11-20210208","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12325-008-0047-5","article-title":"Surgical outcome of intravitreal bevacizumab and filtering surgery in neovascular glaucoma.","volume":"25","author":"Kitnarong","year":"2008","journal-title":"Adv Ther"},{"key":"R25-11-20210208","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2125.2008.03278.x","article-title":"Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up.","volume":"66","author":"Costagliola","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R26-11-20210208","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/jop.2008.0088","article-title":"Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma.","volume":"25","author":"Yuzbasioglu","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"R27-11-20210208","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/112067210901900318","article-title":"The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma.","volume":"19","author":"Gupta","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R29-11-20210208","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/jop.2007.0036","article-title":"Role of intravitreal bevacizumab in neovascular glaucoma.","volume":"23","author":"Gheith","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"R32-11-20210208","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0161-6420(01)00775-8","article-title":"Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma.","volume":"108","author":"Sivak-Callcott","year":"2001","journal-title":"Ophthalmology"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IJG.0b013e3181ccb794","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T08:51:42Z","timestamp":1711356702000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00061198-201012000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0b013e3181ccb794","relation":{},"ISSN":["1057-0829"],"issn-type":[{"value":"1057-0829","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}